Aucatzyl is a CAR T-cell therapy that targets CD19 and has been designed to minimize excessive activation of the programmed T ...
An FDA panel on Thursday endorsed a cryoablation system as an alternative to surgery for some early breast cancer patients.
The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & Innovation, which will build upon longstanding MD Anderson clinical and ...
Men who undergo prostate cancer treatment face a greatly increased risk of life-altering, long-term complications, a new ...
Men who undergo prostate cancer treatment face a greatly increased risk of life-altering, long-term complications, a ...
Hosted on MSN2d
New CAR T-Cell Therapy Approved for Leukemiaof the University of Texas MD Anderson Cancer Center in Houston, said in a statement. Like other CAR T-cell therapies, the ...
The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & ...
Lunit Shows Promise of AI in Predicting Immunotherapy Response for Rare Cancer Patients at SITC 2024
Conducted in collaboration with The University of Texas MD Anderson Cancer Center, this study will be presented at the ...
El Paso Matters on MSN2d
Fort Bliss soldier leads bone marrow registration driveWhat started as a hobby at Fort Bliss for the 24-year-old Army soldier has turned into an effort to make donor registration ...
Dr. Nicole Fleming, a gynecologic oncologist specializing in the treatment of gynecologic malignancies with both surgical and ...
Targeted therapy revolutionized cancer treatment, with gene fusions leading the way when the FDA approved imatinib in 2001 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback